The MediMabBio platform employs systems biology and advanced immunological methods to develop immuno-oncology drugs that effectively target various solid tumors. This platform utilizes rational drug design principles in the discovery of antibodies for large molecule therapeutic development.

Disease Domain	Count

Neoplasms	4
Immune System Diseases	2

Top 5 Drug Type	Count

Monoclonal antibody	2
Antibody fusion proteins	2
Antibody	1
Bispecific antibody	1

Top 5 Target	Count

GITR(Glucocorticoid-induced tumor necrosis factor receptor-related protein)	2
TIGIT(T cell immunoglobulin and ITIM domains)	1
GITR x IL-15	1
IL-15 x TIGIT	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Current Projects

Drug(Targets)	Indications	Global Highest Phase

MFA-011 ( IL-15 x TIGIT )	Neoplasms More	Preclinical
MFA 031 ( GITR )	Autoimmune Diseases More	Preclinical
MMB-102 ( GITR )	Neoplasms More	Discovery
MFA-021 ( GITR x IL-15 )	Neoplasms More	Discovery
MMB-301	Autoimmune Diseases More	Discovery

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis